Brandes Investment Partners LP Has $155.01 Million Holdings in Corteva, Inc. $CTVA

Brandes Investment Partners LP boosted its stake in Corteva, Inc. (NYSE:CTVA) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,312,515 shares of the company’s stock after purchasing an additional 24,985 shares during the quarter. Brandes Investment Partners LP’s holdings in Corteva were worth $155,009,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new position in Corteva during the third quarter worth about $25,000. Redmont Wealth Advisors LLC acquired a new position in Corteva during the third quarter worth about $29,000. Basepoint Wealth LLC acquired a new position in Corteva during the fourth quarter worth about $30,000. Jackson Grant Investment Advisers Inc. raised its stake in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC acquired a new position in Corteva during the third quarter worth about $33,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Citigroup boosted their target price on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. The Goldman Sachs Group boosted their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. UBS Group lowered their target price on Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research note on Tuesday. Finally, Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $88.48.

Corteva Stock Performance

Shares of CTVA stock opened at $74.95 on Wednesday. The business’s 50 day simple moving average is $80.89 and its 200 day simple moving average is $75.17. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The stock has a market capitalization of $50.13 billion, a PE ratio of 44.09, a PEG ratio of 2.32 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the business posted $1.13 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s dividend payout ratio is presently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.